arrow
M

Manuel Salto-Tellez

the institute of cancer research and the royal marsden hospital
H指数:76
被引数:2.9万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The role of DNA mismatch repair status in oesophagogastric cancer treated with perioperative chemotherapy: evidence from the MRC ST03 and OE05 trials

DNA错配修复状态在围手术期化疗治疗的食管胃癌中的角色:来自MRC ST03和OE05试验的证据

2026-08-250
OA
H&E-based MSI/MMR testing with AI in colorectal cancer: a multi-centred blinded evaluation

基于H&E的MSI/MMR联合检测在结直肠癌中的应用:一项多中心盲法评估

2025-12-150
OAAI
ESMO Basic Requirements for AI-based Biomarkers In Oncology (EBAI)

ESMO对基于AI的肿瘤学生物标志物的基本要求 (EBAI)

2025-11-180
OAAI
A Phase Ia/b study of MEK1/2 inhibitor binimetinib with MET inhibitor crizotinib in patients with RAS mutant advanced colorectal cancer (MErCuRIC)

MEK1/2抑制剂比尼美替尼与MET抑制剂克唑替尼在RAS突变型晚期结直肠癌 (汞) 患者中的Ia/b期研究

2025-04-100
OAAI
Implementing digital pathology: qualitative and financial insights from eight leading European laboratories
2025-03-010
OAAI
Genomic characterization of endocrine resistance in ER+HER2+breast cancers in the POETIC Trial
2024-05-020
PRE
Encrypted federated learning for secure decentralized collaboration in cancer image analysis

加密的联邦学习用于癌症图像分析中的安全分散协作

2024-02-0115
OA
Digital pathology for reporting histopathology samples, including cancer screening samples - definitive evidence from a multisite study

用于报告组织病理学样本 (包括癌症筛查样本) 的数字病理学-来自多站点研究的确凿证据

2024-01-172
OAAI
Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: a report of the international immuno-oncology biomarker working group

基于机器学习的乳腺癌肿瘤浸润淋巴细胞评估中的陷阱: 国际免疫肿瘤学生物标志物工作组的报告

2023-08-2312
OAAI
Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

癌症中免疫细胞浸润的空间分析: 当前方法和未来方向。国际乳腺癌免疫肿瘤学生物标志物工作组的报告

2023-08-238
OAAI
Deconstructing the molecular characteristics of ER+HER2+early breast cancer in the POETIC trial using multiplex immunofluorescence and gene expression profiles
2023-03-010
PRE
Immune cell infiltration associated with poor anti-proliferative response to aromatase inhibitors in postmenopausal women with primary ER-positive HER2-negative breast cancer
2023-03-010
PRE